insights_auto
Why is DFTX up 6.19%?
Dive Deeperchevron_right
DFTX:NASDAQ
Definium Therapeutics Inc
$38.41
arrow_upward
+6.19%(+2.24) 1D
$38.27
arrow_downward
-0.36% (-0.14)bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$35.92
High
$39.10
Low
$35.51
Mkt. cap
5.16B
Avg. vol.
2.11M
Volume
12.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$35.92
High
$39.10
Low
$35.51
Mkt. cap
5.16B
Avg. vol.
2.11M
Volume
12.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Simply Wall Street
·
9 hours ago
Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention?
Stock Titan
·
12 hours ago
15 new hires get the right to buy Definium shares in stages over four years
Investing.com Nigeria
·
1 day ago
Form 4 Definium Therapeutics Inc For: 27 September By Investing.com
Stock Traders Daily
·
1 day ago
Discipline and Rules-Based Execution in DFTX Response
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com